About Avrio Biopharma
Avrio Biopharma is a company based in Irvine (United States) founded in 2008 was acquired by Nitto in October 2016.. Avrio Biopharma operates in a competitive market with competitors including Exela Pharma, August Bioservices, ApiJect, Gland Pharma and Vetter Pharma, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Avrio Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avrio Biopharma
Avrio Biopharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Nitto. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified materials are manufactured and supplied for various industries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avrio Biopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avrio Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avrio Biopharma Comparisons
Competitors of Avrio Biopharma
Avrio Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, August Bioservices, ApiJect, Gland Pharma and Vetter Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| domain | founded_year | HQ Location |
Diversified research services for clinical solutions are offered.
|
|
| domain | founded_year | HQ Location |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| domain | founded_year | HQ Location |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| domain | founded_year | HQ Location |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| domain | founded_year | HQ Location |
Developer and manufacturer of pharmaceutical products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Avrio Biopharma
When was Avrio Biopharma founded?
Avrio Biopharma was founded in 2008.
Where is Avrio Biopharma located?
Avrio Biopharma is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
What does Avrio Biopharma do?
Avrio Biopharma was established in 2008 in Irvine, United States, as an injectables contract development and manufacturing organization. Services encompassed cGMP manufacturing, product development, and CMC support within the biopharmaceutical sector. Operations included formulation development, fill and finish processes, clinical supply management, and lyophilization. The company was acquired by Nitto Denko Avecia in October 2016.
Who are the top competitors of Avrio Biopharma?
Avrio Biopharma's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
Who are Avrio Biopharma's investors?
Avrio Biopharma has 1 investor. Key investors include Nitto.